Affymax is a New York-based biotechnology company that develops and commercializes novel therapeutics for the treatment of kidney disease.
Business Model:
Revenue: $15M
Employees: 51-200
Address: 600 Fifth Avenue
City: New York, NY
State: NY
Zip: 10020
Country: US
Affymax is a New York-based biotechnology company that develops and commercializes novel therapeutics for the treatment of kidney disease.
Contact Phone:
+16508128700
Contact Email:
Listed Exchange:
OTCBB
IPO Date:
6/6/2013
Ticker Symbol:
AFFY
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2009 | Venture Round | 3 | $42M |
Bessemer Venture Partners ProQuest Sprout Group ProQuest Bessemer Venture Partners ProQuest Sprout Group ProQuest |
7/2001 | Private Equity Round | 1 | $51M |
Apax Partners Apax Partners |
7/2005 | Series D | 8 | $60M |
Diamond Capital Company Bear Stearns Health Innoventures L.P Merlin Biomed Sprout Group JAFCO Asia Apax Partners Bessemer Venture Partners Bear Stearns Health Innoventures L.P JAFCO Asia MPM Capital Diamond Capital Company Bear Stearns Health Innoventures L.P Merlin Biomed Sprout Group JAFCO Asia Apax Partners Bessemer Venture Partners Bear Stearns Health Innoventures L.P JAFCO Asia |
4/2004 | Series C | 4 | $20M |
Bear Stearns Health Innoventures L.P Sprout Group MPM Capital Apax Partners Bear Stearns Health Innoventures L.P |
12/2006 | IPO | $92.5M |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|